| Jackie R York, MD | |
|
3500 Gaston Ave, 3 Hop - Department Of Neonatology, Dallas, TX 75246-2017 | |
| (214) 820-7604 | |
| (214) 820-2370 |
| Full Name | Jackie R York |
|---|---|
| Gender | Female |
| Speciality | Pediatrics - Neonatal-perinatal Medicine |
| Location | 3500 Gaston Ave, Dallas, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134117559 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080N0001X | Pediatrics - Neonatal-perinatal Medicine | M9756 (Texas) | Primary |
| Entity Name | Pediatrix Medical Group Of Texas Billing Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649377359 PECOS PAC ID: 0042283921 Enrollment ID: O20110907001264 |
News Archive
Scientists have published the first comprehensive catalog of genetic mutations and other abnormal changes found in 279 cancers of the head and neck, and have identified several broken molecular pathways that might be targeted by existing and future cancer drugs.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC) with insufficient response or intolerance to immunosuppressants and / or biologics when treated with between five and eight sessions with Adacolumn.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
The PTR Group, a leading real-time and embedded technology engineering services provider, today announced that it has agreed to sponsor three high school teams for the 2010 season of the US FIRST Robotics Competition (http://usfirst.org).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jackie R York, MD 3500 Gaston Ave, 3 Hob - Department Of Neonatology, Dallas, TX 75246-2017 Ph: (214) 820-7604 | Jackie R York, MD 3500 Gaston Ave, 3 Hop - Department Of Neonatology, Dallas, TX 75246-2017 Ph: (214) 820-7604 |
News Archive
Scientists have published the first comprehensive catalog of genetic mutations and other abnormal changes found in 279 cancers of the head and neck, and have identified several broken molecular pathways that might be targeted by existing and future cancer drugs.
A novel study published in Restorative Neurology and Neuroscience provides the first evidence that a simple and inexpensive non-invasive speech-to-touch sensory substitution device has the potential to improve hearing in hearing-impaired cochlear implant patients, as well as individuals with normal hearing, to better discern speech in various situations like learning a second language or trying to deal with the "cocktail party effect."
Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC) with insufficient response or intolerance to immunosuppressants and / or biologics when treated with between five and eight sessions with Adacolumn.
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, and Javelin Pharmaceuticals, Inc., today announced that the companies have entered into a definitive merger agreement providing for the acquisition of Javelin by Hospira for $2.20 per share in cash, or approximately $145 million. Hospira expects to commence a tender offer for all outstanding shares of Javelin common stock on or about April 21, 2010, in accordance with the terms of the merger agreement.
The PTR Group, a leading real-time and embedded technology engineering services provider, today announced that it has agreed to sponsor three high school teams for the 2010 season of the US FIRST Robotics Competition (http://usfirst.org).
› Verified 2 days ago
Dr. Jyothsna Gattineni, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3438 | |
Ruth Osei Fordjour, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 12221 Merit Dr, Suite 1500, Dallas, TX 75251 Phone: 214-957-4754 | |
Dr. Alecia Curlene Nero, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-4180 | |
Dr. Sravani Avula, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-730-5437 | |
Asif Zia Khattak, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 3500 Gaston Ave, Dallas, TX 75246 Phone: 214-820-7604 | |
Sadia Malik, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-456-2533 Fax: 214-456-8130 | |
Sana Jamil Siddiqui, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5323 Harry Hines Boulevard, Dallas, TX 75390 Phone: 214-456-0488 Fax: 214-456-4486 |